Physiological markers linked to levodopa emerge during deep brain stimulation for Parkinson’s
Parkinson’s disease treatment is entering an era in which the brain may no longer be viewed as a static target, ...
Parkinson’s disease treatment is entering an era in which the brain may no longer be viewed as a static target, ...
Parkinson’s disease is often described as a disorder of movement, but a new study suggests that the illness may also ...
Parkinson’s disease and multiple system atrophy can begin with remarkably similar symptoms: slowed movement, stiffness, tremor, balance problems and changes ...
Researchers at Weill Cornell Medicine have revealed how LRRK2, a protein strongly associated with Parkinson’s disease, switches between inactive and ...
Parkinson’s disease is widely recognized for its tremor, slowed movement and muscle rigidity, but a new study is drawing attention ...
A new study is bringing molecular precision to one of Parkinson’s disease’s most important biological puzzles: why changes in the ...
Parkinson’s disease research is increasingly turning its attention away from neurons alone. A new study by Smits, Magni, Grzyb and ...
Parkinson’s disease is often described as a disorder of movement, but one of its most disabling symptoms can be defined ...
A surprising discovery in Parkinson’s disease research is challenging one of the field’s most familiar assumptions: that restoring movement necessarily ...
A team led by Del Popolo and colleagues reports that aggregated α-synuclein—an established driver of Parkinson’s disease pathology—does not affect ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine